Literature DB >> 24146269

Associated morbidity of nasolacrimal duct obstruction--a large community based case-control study.

Arie Y Nemet1, Shlomo Vinker.   

Abstract

BACKGROUND: To evaluate the prevalence and risk factors of various conditions among patients with nasolacrimal duct obstruction (NLDO).
METHODS: A retrospective, observational case control study of 2,615 patients diagnosed with NLDO in the Central District of Clalit Health Services HMO in Israel, from 2003 to 2012; 15,650 control patients were randomly selected from the district HMO members. Medical and socio-demographic information were extracted from patients' electronic medical records. The prevalence of various ocular and systemic conditions as risk factors for NLDO was calculated.
RESULTS: The average age of NLDO patients was 68.3 ± 14.9 years, 34.4 % were male. Age (p < 0.001), ischemic heart disease (OR = 1.29; CI: 1.15-1.44), glaucoma (OR = 1.17; CI: 1.01-1.36), allergic conjunctivitis (OR = 3.59; CI: 3.28-3.94), dry eye (OR = 1.43; CI: 1.31-1.58), epiphora (OR = 6.34; CI: 5.09-7.91), and allergic rhinitis (OR = 1.51; CI: 1.33-1.71) were significantly associated with NLDO. Smoking (OR = 0.86; CI: 0.77-0.96) was significantly less prevalent among NLDO patients.
CONCLUSIONS: The etiology of NLDO is multifactorial. The prevalence of associated demographic, systemic, and periocular conditions varies. A better understanding of the patho-physiological association between these factors and NLDO may help its prevention and treatment.

Entities:  

Mesh:

Year:  2013        PMID: 24146269     DOI: 10.1007/s00417-013-2484-3

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  36 in total

1.  Epidemiology of pterygium in Victoria, Australia.

Authors:  C A McCarty; C L Fu; H R Taylor
Journal:  Br J Ophthalmol       Date:  2000-03       Impact factor: 4.638

2.  Primary acquired nasolacrimal duct obstruction. A clinicopathologic report and biopsy technique.

Authors:  J V Linberg; S A McCormick
Journal:  Ophthalmology       Date:  1986-08       Impact factor: 12.079

3.  Frequency and risk factors for pterygium in the Barbados Eye Study.

Authors:  R Luthra; B B Nemesure; S Y Wu; S H Xie; M C Leske
Journal:  Arch Ophthalmol       Date:  2001-12

4.  Pathogenesis of primary acquired nasolacrimal duct obstruction.

Authors:  Mohsen Bahmani Kashkouli; Alireza Sadeghipour; Reza Kaghazkanani; Azar Bayat; Farzad Pakdel; Gholam Hosseyn Aghai
Journal:  Orbit       Date:  2010-02

5.  Unrecordable pulsatile ocular blood flow may signify severe stenosis of the ipsilateral internal carotid artery.

Authors:  Y Barkana; A Harris; L Hefez; M Zaritski; D Chen; I Avni
Journal:  Br J Ophthalmol       Date:  2003-12       Impact factor: 4.638

6.  Dacryocystorhinostomy: a review of 119 cases.

Authors:  C L Zolli; G M Shannon
Journal:  Ophthalmic Surg       Date:  1982-11

7.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.

Authors:  K G Alberti; P Z Zimmet
Journal:  Diabet Med       Date:  1998-07       Impact factor: 4.359

8.  Prevalence of pterygium in Latinos: Proyecto VER.

Authors:  S West; B Muñoz
Journal:  Br J Ophthalmol       Date:  2009-06-30       Impact factor: 4.638

9.  Foreshortening of the inferior conjunctival fornix associated with chronic glaucoma medications.

Authors:  I R Schwab; J V Linberg; V M Gioia; W H Benson; G M Chao
Journal:  Ophthalmology       Date:  1992-02       Impact factor: 12.079

10.  Effects of beta-adrenergic antagonist on width of nasolacrimal drainage system lumen.

Authors:  Junji Narioka; Yuichi Ohashi
Journal:  J Ocul Pharmacol Ther       Date:  2007-10       Impact factor: 2.671

View more
  4 in total

1.  Etiology, diagnosis, management and outcomes of epiphora referrals to an oculoplastic practice.

Authors:  Guang-Lin Shen; John D Ng; Xiao-Ping Ma
Journal:  Int J Ophthalmol       Date:  2016-12-18       Impact factor: 1.779

2.  'Stenting the Lacrimal System in Modified Denker's for Mucormycosis: Really Needed!'-A Longitudinal Study.

Authors:  Rahul Gupta; Sanket R Shukla; Ranjankrishnan G Aiyer
Journal:  J Maxillofac Oral Surg       Date:  2022-02-21

3.  Nine-Month Follow-up Results of Treatment for Nasolacrimal Duct Obstruction by Probing with Adjunctive Mitomycin C in Adults: A Prospective Randomized Placebo-Controlled Trial.

Authors:  Nader Dehghani; Mohamad Reza Fouladivanda; Mohamed Amin Ghobadifar; Gelayol Safshekan-Esfahani; Armin Akbarzadeh
Journal:  Chonnam Med J       Date:  2015-04-14

4.  Rebamipide promotes lacrimal duct epithelial cell survival via protecting barrier function.

Authors:  Hiroshi Tanaka; Tomomichi Nakayama; Michiko Tsukamoto; Akihide Watanabe; Takahiro Nakamura; Norihiko Yokoi; Chie Sotozono; Shigeru Kinoshita
Journal:  Sci Rep       Date:  2020-02-03       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.